AGM/EGM21 Aug 2026, 04:13 pm
Gujarat Terce Approves Re-appointment of MD & CEO
AI Summary
Gujarat Terce Laboratories Ltd announced the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a term of three years, effective October 28, 2026, to October 27, 2029. The approval was granted by the company's members at the 41st Annual General Meeting held on August 21, 2026. Mr. Prajapati brings over 15 years of experience in the pharmaceutical sector, with expertise in business strategy, operations, marketing, and business development. He holds a management qualification from B.K. School of Business Management. The disclosure also notes his relationship as son to Mr. Natwarbhai Prajapati, a Whole-Time Director.
Key Highlights
- Mr. Aalap Prajapati re-appointed as MD & CEO for three years.
- Term of re-appointment: October 28, 2026, to October 27, 2029.
- Approval received at the 41st Annual General Meeting.
- Mr. Prajapati has 15+ years of experience in the pharma sector.
- He is the son of existing Whole-Time Director, Mr. Natwarbhai Prajapati.
Price Impact
More from GUJTERC